Postprandial consequences of lipid absorption in the onset of obesity: Role of intestinal CD36

Archive ouverte

Lebrun, Lorène J | Moreira Milheiro, Sarah | Tavernier, Annabelle | Niot, Isabelle

Edité par CCSD ; Elsevier -

International audience. Obesity has reached epidemic proportions and its incidence is still increasing. Obesity is an excess of fat, which can have harmful consequences such as inflammation, insulin resistance or dyslipidemia. Taken together, these conditions are known as metabolic syndrome (MetS). More and more studies consider obesity from a postprandial perspective: parameters such as triglyceridemia, endotoxemia or hormone secretion may have deeper postprandial metabolic consequences than during the fasting state. These effects take even more importance when we consider that humans spend more than half of the day in a postprandial state. This review focuses on the postprandial state in a fat-enriched diet and on the consequences of intestinal lipid absorption, putting the intestine in a central place in the development of obesity / MetS. Finally, we describe the crucial role of the lipid receptor cluster of differentiation 36 (CD36) for gut lipid absorption and the alterations that occur in CD36 dysfunction.

Suggestions

Du même auteur

Lipopolysaccharides and glucagon-like peptide 1 : from molecular mechanisms to pathophysiology. Lipopolysaccharides et glucagon-like peptide 1 : des mécanismes moléculaires à la physiopathologie

Archive ouverte | Lebrun, Lorène J | CCSD

Obesity and type 2 diabetes are metabolic diseases which have reached epidemic proportions worldwide. These metabolic disorders are related to a low grade inflammation whose molecular origin is still unknown. Previous studies have...

Could glucagon-like peptide-1 be a potential biomarker of early-stage intestinal ischemia?

Archive ouverte | Lebrun, Lorène J | CCSD

International audience. Intestinal ischemia, also called mesenteric ischemia, is a severe gastrointestinal and vascular medical emergency caused by a sudden decrease of blood flow through the mesenteric vessels. It ...

Phospholipid transfer protein (PLTP), lipopolysaccharides detoxification and metabolic diseases: a connection ?

Archive ouverte | Lebrun, Lorène J | CCSD

International audience

Chargement des enrichissements...